Ig Glycosylation in Ulcerative Colitis: It’s Time for New Biomarkers

Ig Glycosylation in Ulcerative Colitis: It’s Time for New Biomarkers

Background: Ulcerative colitis (UC) is a chronic relapsing disease, which needs a continue monitoring, especially during biological therapies. An increasing number of patients is treated with anti-Tumor Necrosis factor (TNF) drugs, and current research is focalized to identify biomarkers able to mon...

Full description

Bibliographic Details
Main Authors: Riccardo Capecchi, Paola Migliorini, Federico Zanzi, Simona Maltinti, Ilaria Puxeddu, Nicola de Bortoli, Massimo Bellini, Francesco Costa, Santino Marchi, Lorenzo Bertani
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Pharmacology
Subjects:
Ulcerative colitis
IBD
Biomarker
anti-TNF
glycosylation
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.654319/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.654319/full

Similar Items